Inzy earnings
WebQuarterly Numbers. Actuals. Estimates. INZY will report Q1 2024 earnings on 09/07/2024. Q1 2024. Q2 2024. Q3 2024. Web29 mrt. 2024 · Inozyme Pharma, Inc. (NASDAQ:INZY – Get Rating) – Jefferies Financial Group issued their Q1 2024 earnings estimates for shares of Inozyme Pharma in a research note issued on Wednesday, March 22nd.Jefferies Financial Group analyst S. Jeong anticipates that the company will earn ($0.44) per share for the quarter. Jefferies …
Inzy earnings
Did you know?
Web31 mrt. 2024 · INZY Inozyme Pharma, Inc. Earnings Surprise 745 followers $5.73 1.04 ( +22.17%) 4:00 PM 03/31/23 NASDAQ $USD Post-Market: $5.67 -0.06 (-1.05%) 7:56 PM Summary Ratings Financials Earnings... Web24 mrt. 2024 · INZY support price is $3.10 and resistance is $3.50 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that INZY stock will trade within this expected range on the day.
WebEarnings Summary For their last quarter, Inozyme Pharma (INZY) reported earnings of -$0.38 per share, beating the Zacks Consensus Estimate of $-0.43 per share. This reflects a positive... Web22 mrt. 2024 · The following information was filed by Inozyme Pharma, Inc. (INZY) on Wednesday, March 22, 2024 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the …
WebFor their last quarter, Inozyme Pharma (INZY) reported earnings of -$0.38 per share, beating the Zacks Consensus Estimate of $-0.43 per share. This reflects a positive … Web13 apr. 2024 · We are developing INZ-701, an enzyme therapy, to address pathologic mineralization and intimal proliferation which can drive morbidity and mortality in these severe diseases. INZ-701 is currently in Phase 1/2 clinical trials for the treatment of ENPP1 Deficiency and ABCC6 Deficiency. View Corporate Presentation Stock Quote Change
WebYou can buy and sell Inozyme Pharma (INZY) and other stocks, ETFs, and options commission-free on Robinhood with real-time quotes, market data, and relevant news. …
Web16 mrt. 2024 · This suggests that analysts have very recently bumped up their estimates for INZY, giving the stock a Zacks Earnings ESP of +12.11% heading into earnings season. Inozyme Pharma, Inc. Price... greenwashing refers toWeb2 dagen geleden · Inozyme Pharma (INZY) (Delayed Data from NSDQ) $5.89 USD +0.45 (8.27%) Updated Apr 11, 2024 04:00 PM ET After-Market: $5.89 0.00 (0.00%) 7:58 PM … fnf winterWeb6 apr. 2024 · Jefferies Financial Group Weighs in on Inozyme Pharma, Inc.'s Q1 2024 Earnings (NASDAQ:INZY) americanbankingnews.com - March 29 at 1:38 AM: Here's Why Inozyme Pharma Has My Attention finance.yahoo.com - March 28 at 10:53 AM: Q1 2024 EPS Estimates for Inozyme Pharma, Inc. (NASDAQ:INZY) Increased by Analyst … fnf wireframe instrumentalWeb12 apr. 2024 · Check if INZY Stock has a Buy or Sell Evaluation. INZY Stock Price (NASDAQ), Forecast, Predictions, ... The upcoming earnings date for Inozyme Pharma, Inc. is 2024-05-09 00:00:00. Click to get the best stock tips daily for … fnf winyWeb11 apr. 2024 · BOSTON, April 11, 2024 (GLOBE NEWSWIRE) — Inozyme Pharma, Inc. (Nasdaq: INZY), a clinical- stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of pathologic mineralization and intimal proliferation, today announced Douglas A. Treco, Ph.D., the company’s chief executive officer and chairman … fnf wireframe backgroundWebInozyme Pharma (INZY) will release its next earnings report on May 10, 2024. In the last quarter Inozyme Pharma reported -$0.452 EPS in relation to -$0.31 expected by the market. fnf wireframe onlinesequencerWebInozyme Pharma, Inc. (INZY) NasdaqGS - NasdaqGS Real Time Price. Currency in USD. Follow. 2W 10W 9M. 4.9350 -0.1950 (-3.80%) At close: 04:00PM EDT. 4.9000 -0.03 ( … greenwashing reclames